中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Advance in the study about the inhibitors of PTPIB - a novel target for diabetes and obesity therapy

文献类型:期刊论文

作者ZHANG Wei; LI JingYa; LI Jia
刊名Chinese Bulletin of Life Sciences
出版日期2006
卷号18期号:5页码:462-466
关键词PTP1B PTP1B insulin signaling pathway negative regulation diabetes and obesity inhibitors of PTP1B
ISSN号1004-0374
其他题名糖尿病和肥胖症治疗新靶点PTP1B抑制剂的研究进展
文献子类Review
英文摘要Protein tyrosine phosphatase 1 B (PTP1B) is a typical member of non-receptor PTP family. PTP1B plays an important role in the negative regulation of insulin signaling pathway. It has been proved to be a novel target for diabetes and obesity. Inhibition of PTP1B's activity could improve the sensitivity of insulin signaling. The discovery of highly effective inhibitors of PTP1B has a promising application in diabetes and obesity therapy.
资助项目国家自然科学基金青年科学基金项目[00000000]
WOS研究方向Biochemistry & Molecular Biology (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:2547942
源URL[http://119.78.100.183/handle/2S10ELR8/268257]  
专题药物发现与设计中心
作者单位National Center for Drug Screening, Shanghai Institute of Medica Meteria, The Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
ZHANG Wei,LI JingYa,LI Jia. Advance in the study about the inhibitors of PTPIB - a novel target for diabetes and obesity therapy[J]. Chinese Bulletin of Life Sciences,2006,18(5):462-466.
APA ZHANG Wei,LI JingYa,&LI Jia.(2006).Advance in the study about the inhibitors of PTPIB - a novel target for diabetes and obesity therapy.Chinese Bulletin of Life Sciences,18(5),462-466.
MLA ZHANG Wei,et al."Advance in the study about the inhibitors of PTPIB - a novel target for diabetes and obesity therapy".Chinese Bulletin of Life Sciences 18.5(2006):462-466.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。